6446 PharmaEssentia Corp.
PharmaEssentia Corp. (6446) announced important resolutions from the 2026 Annual General Meeting (acted by the board of directors) of its major subsidiary, Pan-Asia Medical Products Co., Ltd. These include the approval of the 2025 loss compensation plan and the 2025 financial and business reports.
📋 Article Processing Timeline
- 📰 Published: May 16, 2026 at 12:57
- 🔍 Collected: May 16, 2026 at 12:57 (0 min after Published)
- 🤖 AI Analyzed: May 16, 2026 at 13:14 (17 min after Collected)
Report Date: May 16, 2026
Announcement Date: May 15, 2026
Announcement Time: 16:09:50
Company Code: 6446
Company Name: PharmaEssentia Corp.
Subject: Announcement of important resolutions from the 2026 Annual General Meeting (acted by the board of directors) of the company's important subsidiary, Pan-Asia Medical Products Co., Ltd.
Applicable Clause: Article 18
Occurrence Date: May 15, 2026
Explanation:
1. Date of Annual General Meeting: May 15, 2026
2. Important Resolution One, Profit Distribution or Loss Compensation: Approval of the 2025 loss compensation plan.
3. Important Resolution Two, Amendment to Articles of Association: None.
4. Important Resolution Three, Business Report and Financial Statements: Approval of the 2025 financial report and business report.
5. Important Resolution Four, Election of Directors and Supervisors: None.
6. Important Resolution Five, Other Matters: None.
7. Other matters to be specified: None.
Announcement Date: May 15, 2026
Announcement Time: 16:09:50
Company Code: 6446
Company Name: PharmaEssentia Corp.
Subject: Announcement of important resolutions from the 2026 Annual General Meeting (acted by the board of directors) of the company's important subsidiary, Pan-Asia Medical Products Co., Ltd.
Applicable Clause: Article 18
Occurrence Date: May 15, 2026
Explanation:
1. Date of Annual General Meeting: May 15, 2026
2. Important Resolution One, Profit Distribution or Loss Compensation: Approval of the 2025 loss compensation plan.
3. Important Resolution Two, Amendment to Articles of Association: None.
4. Important Resolution Three, Business Report and Financial Statements: Approval of the 2025 financial report and business report.
5. Important Resolution Four, Election of Directors and Supervisors: None.
6. Important Resolution Five, Other Matters: None.
7. Other matters to be specified: None.